Pharmaceutical manufacturing is a complex journey. From the initial discovery of a potential drug to its eventual arrival in the hands of…
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
“New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…
Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase (phase 2 and beyond) are critical to the…
Executive Summary In this detailed exploration, We explore the detailed journey of Hycon pharma solutions, a global pharmaceutical powerhouse, in their quest…